For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Biopure Corporation

USPTO Granted Patents = 37

% Expired Patents = 21.6

Trademarks = 4

Forward Citations = 559

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

William Richard Light (20 out of 22 patents)

Maria S Gawryl (17 out of 17 patents)

Robert A Houtchens (16 out of 17 patents)

4. Carl W Rausch (13 out of 14 patents)

5. Anthony J Laccetti (5 out of 11 patents)

6. Bing L Wong (5 out of 5 patents)

7. Yung-Pin Chen (4 out of 9 patents)

8. Mario J Feola (4 out of 7 patents)

9. Thomas C Page (4 out of 5 patents)

10. Edward E Jacobs, Jr (4 out of 4 patents)

11. Yong-Qiang Shen (4 out of 4 patents)

12. Beverly A Teicher (3 out of 9 patents)

13. Jose O Torres (2 out of 2 patents)

14. Robert E Hopkins, 2nd (2 out of 2 patents)

15. Javed Baqai (1 out of 1 patent)

37 patents: Sort by Forward Citations

1. 7553613 - Use of defibrinated blood for manufacture of hemoglobin-based oxygen carrier (2009-06-30),

2. 7459535 - Method of forming a polymerized hemoglobin solution from stabilized hemoglobin (2008-12-02),

3. 7267817 - Method for improving oxygen transport by stored red blood cells (2007-09-11),

4. 7135554 - Method of forming a polymerized hemoglobin solution from stabilized hemoglobin (2006-11-14),

5. 7041800 - Preserving a hemoglobin blood substitute with a transparent overwrap (2006-05-09),

6. 7041799 - Preserving a hemoglobin blood substitute with a transparent overwrap (2006-05-09),

7. 7001715 - Purification of red blood cells by separation and diafiltration (2006-02-21),

8. 6986984 - Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier (2006-01-17),

9. 6811778 - Method for improving oxygen transport by stored red blood cells (2004-11-02),

10. 6610832 - Preserving a hemoglobin blood substitute with a transparent overwrap (2003-08-26),

11. 6541449 - Increasing function of organs having reduced red blood cell flow (2003-04-01),

12. 6518010 - Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier (2003-02-11),

13. 6506725 - Ultra pure hemoglobin solutions and blood-substitutes (2003-01-14),

14. 6288027 - Preserving a hemoglobin blood substitute with a transparent overwrap (2001-09-11),

15. 6271351 - Method for preserving a hemoglobin blood substitute (2001-08-07),

Biopure Corporation is a biopharmaceutical company that develops and markets oxygen therapeutics and veterinary products. The company's main product, Hemopure, is an oxygen therapeutic used for the treatment of acute anemia in certain medical situations. Biopure also produces veterinary products such as Oxyglobin, a similar oxygen therapeutic for animals. The company is dedicated to improving patient care and enhancing veterinary medicine through its innovative products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Biopure Corporation

37 Patents

#75 in Cambridge, MA

#537 in Massachusetts

#9,231 in US

#18,212 in the World

Cambridge, MA, United States of America

Biopure Corporation

Forward Citations = 559

20 inventors:

William Richard Light (20 out of 22 patents)

Maria S Gawryl (17 out of 17 patents)

Robert A Houtchens (16 out of 17 patents)

4. Carl W Rausch (13 out of 14 patents)

5. Anthony J Laccetti (5 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…